Yellow Fever Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032),| Key Companies – Sanofi, Takeda, GlaxoSmithKline, Novartis, GE Healthcare

Yellow Fever Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032),| Key Companies - Sanofi, Takeda, GlaxoSmithKline, Novartis, GE Healthcare
DelveInsight Business Research LLP
DelveInsight’s “Yellow Fever Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Yellow Fever, historical and forecasted epidemiology as well as the Yellow Fever market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight’s “Yellow Fever Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Yellow Fever, historical and forecasted epidemiology as well as the Yellow Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 Yellow Fever Overview

Yellow fever is a viral disease of typically short duration. In most cases, symptoms include fever, chills, loss of appetite, nausea, muscle pains – particularly in the back – and headaches. Symptoms typically improve within five days. In about 15% of people, within a day of improving, the fever returns, abdominal pain occurs, and liver damage begins causing yellow skin. If this occurs, the risk of bleeding and kidney problems is increased.

The disease is caused by the yellow fever virus and is spread by the bite of an infected mosquito. It infects humans, other primates, and several types of mosquitoes. In cities, it is spread primarily by Aedes aegypti, a type of mosquito found throughout the tropics and subtropics. The virus is an RNA virus of the genus Flavivirus. The disease may be difficult to tell apart from other illnesses, especially in the early stages. To confirm a suspected case, blood-sample testing with polymerase chain reaction is required.

Yellow Fever Epidemiology Insights

  • Approximately 200,000 cases of yellow fever occur annually; 90% of them occur in Africa. A dramatic resurgence of yellow fever has occurred since the 1980s in sub-Saharan Africa and South America. 

  • A series of epidemics and smaller outbreaks of yellow fever that occurred in West African countries were primarily responsible for the increased incidence of yellow fever in Africa, but the first epidemic reported in Kenya in >2 decades signaled a change in the distribution of the disease was also occurring. Transmission in Africa is maintained by a high density of vector mosquito populations that are in close proximity to largely unvaccinated human populations. Although some countries have incorporated yellow fever vaccines into childhood immunization programs, vaccine coverage is not optimal.

Click here to learn more about the Yellow Fever Market Landscape

The Report Covers the Yellow Fever Epidemiology Segmented by:

  • Total Yellow Fever incident cases,  

  • Total Yellow Fever diagnosed cases, 

  • Total Yellow Fever prevalent cases 

  • Total Yellow Fever treatment cases 

Yellow Fever Market Outlook

The Yellow Fever market outlook of the report helps to build a detailed comprehension of the historic, current and forecasted Yellow Fever market trends by analyzing the impact of current Yellow Fever therapies on the market, Yellow Fever unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of the Yellow Fever market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Yellow Fever market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Yellow Fever market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Companies Working in the Yellow Fever Market

  • Sanofi 

  • Takeda 

  • GlaxoSmithKline

  • Novartis 

  • GE Healthcare  

And many others 

Yellow Fever Therapies Covered and Analyzed in the Report:

  • HydroVax-002 YFV

  • Galidesivir

  •  YF-17D

  •  Rouvax

  • Tritanrix

And many others 

Learn more about the Key Companies and Emerging Therapies in the Yellow Fever Market

Table of Contents 

  1. Key Insights 

  2. Yellow Fever Introduction 

  3. Executive Summary of Yellow Fever  

  4. Disease Background and Overview

  5. Epidemiology and patient population

  6. Yellow Fever Emerging Therapies

  7. Yellow Fever Market Outlook

  8. Market Access and Reimbursement of Therapies

  9. Market Drivers 

  10. Market Barriers 

  11. Appendix

  12. Report Methodology

  13. DelveInsight Capabilities

  14. Disclaimer

Learn about the detailed offerings of the report @ Yellow Fever Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services


Posted

in

by

Tags: